📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Exploiting novel placental homing peptides for targeted drug delivery in breast Cancer. (2025)

First Author: Alobaid AA

Attributed to: Developing personalized nanotherapies to target placental abnormalities causing fetal growth restriction funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.nano.2025.102805

PubMed Identifier: 39855443

Publication URI: http://europepmc.org/abstract/MED/39855443

Type: Journal Article/Review

Parent Publication: Nanomedicine : nanotechnology, biology, and medicine

ISSN: 1549-9634